Partner Treatment for Bacterial Vaginosis - Clinician Survey: Identifying barriers and enablers to male partner treatment from a clinician perspective

The paradigm of Bacterial Vaginosis (BV) is changing, with our understanding of transmission and treatment rapidly evolving due to recent research.

A randomised controlled trial by researchers at Monash University and Melbourne Sexual Health Centre (MSHC), published recently in the New England Journal of Medicine, has proven that treating an exclusive regular sexual partner (with a penis) at the same time as providing routine BV treatment, can significantly increase cure rates and reduce recurrence of BV.

At MSHC we are surveying clinicians involved in the management of BV, to better understand their perspectives on the use of partner treatment, specifically identifying any barriers or enablers to be able to guide implementation.

The ethics-approved survey is short and anonymous, with participants benefitting from direct access to links from the MSHC website, to guidelines and resources which support these changing recommendations.